Related Experiment Video

Updated: Aug 7, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

Epidermal growth factor receptor structure, regulation, mitogenic signalling and effects of activation

P Boulougouris1, J Elder

  • 1Academic Department of Surgery, Keele University, Stoke-on Trent, Staffordshire, UK.

Anticancer Research
|November 29, 2001
PubMed

Insights

Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) activate cell surface receptors, initiating signaling pathways. This receptor activation stimulates cell proliferation, differentiation, and other key cellular processes.

Area of Science:

  • Cell biology
  • Molecular signaling
  • Biochemistry

Background:

  • Epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha) are key signaling molecules.
  • Their biological effects are mediated through a specific cell surface receptor, the EGF receptor (EGFr).
  • The intracellular domain of EGFr shares structural similarities with retroviral protein tyrosine kinases.

Purpose of the Study:

  • To elucidate the mechanism by which EGF and TGF-alpha binding to their receptor triggers intracellular signaling cascades.
  • To understand the structural and functional changes in the receptor upon ligand binding.
  • To identify downstream signaling events and their impact on cellular responses.

Main Methods:

  • The study likely involved biochemical assays to analyze receptor dimerization and phosphorylation.
  • Enzyme activity assays were probably used to assess the interaction with and phosphorylation of downstream enzymes like phospholipase-C.
  • Cellular assays may have been employed to observe changes in proliferation, morphology, and differentiation.

Main Results:

  • Ligand binding induces a conformational change in the extracellular domain, leading to receptor dimerization.
  • Dimeric receptors exhibit increased catalytic activity and rapid phosphorylation.
  • Phosphorylated receptors associate with and phosphorylate enzymes such as phospholipase-C, altering their function and localization.

Conclusions:

  • EGFr activation by EGF and TGF-alpha initiates a signaling cascade involving receptor dimerization and phosphorylation.
  • This process leads to the modulation of downstream enzymes, impacting cellular processes.
  • The EGFr system plays a crucial role in regulating cell proliferation, morphology, paracrine effects, and differentiation.

More Related Videos

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...